Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin plasma membrane transport protein (SERT), encoded by the SLC6A4 gene, is responsible for the reuptake of serotonin from the synaptic cleft into presynaptic neurons. This process terminates serotonergic signaling and recycles serotonin. SERT is a target for antidepressant drugs like SSRIs and tricyclic antidepressants. Genetic variations in SLC6A4 are associated with various psychiatric conditions.
Inhibition of serotonin reuptake, leading to increased extracellular serotonin levels
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Plasma Membrane Transport Protein (SERT).